Search research articles
Contact Us
Filters
Showing results (241-250 of 274) with videos related to
Page
of 28
Sort By:
Journal of Clinical Medicine
|
March 25, 2022
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Kristin Larsen, Horace Spencer, Meera Mohan, et al.
Haematologica
|
March 16, 2012
Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
Tarun K Garg, Susann M Szmania, Junaid A Khan, et al.
British Journal of Haematology
|
August 28, 2024
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies
Othman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi, et al.
The Lancet. Oncology
|
July 22, 2014
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
Frits van Rhee, Raymond S Wong, Nikhil Munshi, et al.
Nature Communications
|
January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
Eileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
Blood
|
May 23, 2018
The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
Leo Rasche, Edgardo J Angtuaco, Terri L Alpe, et al.
Experimental Hematology & Oncology
|
August 23, 2025
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition
Hayley M Sabol, Aric Anloague, Japneet Kaur, et al.
The Journal of Clinical Investigation
|
August 14, 2019
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease
David C Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2022
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma
Parvathi Sudha, Aarif Ahsan, Cody Ashby, et al.
Blood
|
November 16, 2006
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D Shaughnessy, Fenghuang Zhan, Bart E Burington, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 274) with videos related to
Sort By:
Page
of 28
Journal of Clinical Medicine
|
March 25, 2022
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
Kristin Larsen, Horace Spencer, Meera Mohan, et al.
Haematologica
|
March 16, 2012
Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
Tarun K Garg, Susann M Szmania, Junaid A Khan, et al.
British Journal of Haematology
|
August 28, 2024
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies
Othman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi, et al.
The Lancet. Oncology
|
July 22, 2014
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
Frits van Rhee, Raymond S Wong, Nikhil Munshi, et al.
Nature Communications
|
January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
Eileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
Blood
|
May 23, 2018
The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma
Leo Rasche, Edgardo J Angtuaco, Terri L Alpe, et al.
Experimental Hematology & Oncology
|
August 23, 2025
Healing of lytic lesions and restoration of bone health in multiple myeloma through sclerostin inhibition
Hayley M Sabol, Aric Anloague, Japneet Kaur, et al.
The Journal of Clinical Investigation
|
August 14, 2019
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease
David C Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 6, 2022
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma
Parvathi Sudha, Aarif Ahsan, Cody Ashby, et al.
Blood
|
November 16, 2006
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D Shaughnessy, Fenghuang Zhan, Bart E Burington, et al.
Page
of 28